Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayDec 07, 2016 5:30 pm

Second Sight Medical Products (EYES) Starts Presentation at LD Micro Main Event

Second Sight Medical Products (NASDAQ: EYES) develops, manufactures and markets implantable prosthetic devices to restore functional vision to blind patients. The company's Argus II System is an implantable neurostimulation device that uses electrical stimulation of the retina to replace the function of the defunct photo-receptors in retinitis pigmentosa patients. The company sells its Argus II System to university hospitals, large medical centers, and distributors. For more information, visit the company's website at www.2-sight.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and…

Continue Reading

WednesdayDec 07, 2016 5:00 pm

Chanticleer Holdings (HOTR) Starts Presentation at LD Micro Main Event

Chanticleer Holdings (NASDAQ: HOTR) owns, operates and franchises fast casual and full-service dining concepts in the United States and internationally. The company's portfolio of restaurants include establishments under the Hooters, American Burger Company, The Burger Joint, BT's Burger Joint, Little Big Burger, and Just Fresh names. For more information, visit the company's website atwww.chanticleerholdings.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and…

Continue Reading

WednesdayDec 07, 2016 5:00 pm

CytoDyn (CYDY) Starts Presentation at LD Micro Main Event

CytoDyn (OTC: CYDY) is a biotechnology company focused on the clinical development and commercialization of humanized monoclonal antibodies for the treatment and prevention of human immunodeficiency virus infection. The company's monoclonal antibodies under development for HIV infection are PRO 140, a therapeutic anti-viral agent, which is in phase III clinical trial for treating persons infected with HIV; CytoFeline, a phase II clinical trial anti-LFA-1 antibody for the treatment of feline immunodeficiency virus infection; and Cytolin, a preclinical trial product for the treatment of HIV infection. For more information, visit the company's website at www.cytodyn.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news…

Continue Reading

WednesdayDec 07, 2016 5:00 pm

RCI Hospitality Holdings (RICK) Starts Presentation at LD Micro Main Event

RCI Hospitality Holdings (NASDAQ: RICK) owns and operates upscale adult nightclubs serving primarily businessmen and professionals in the United States. The company operates in two segments: Nightclubs and Bombshells Restaurants and Bars. RCI Hospitality operates adult nightclubs under the brands: Rick's Cabaret, Tootsie's Cabaret, Club Onyx, XTC Cabaret, Cabaret East, Cabaret North, Silver City, Downtown Cabaret, Temptations, Jaguars, The Black Orchid, Seville, and Down in Texas Saloon. For more information, visit the company's website at www.rcihospitality.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted…

Continue Reading

WednesdayDec 07, 2016 5:00 pm

MabVax Therapeutics Holdings (MBVX) Starts Presentation at LD Micro Main Event

MabVax Therapeutics Holdings (NASDAQ: MBVX) is a clinical-stage biopharmaceutical company engaged in the discovery, development and commercialization of proprietary human monoclonal antibody products and vaccines for the diagnosis and treatment of various cancers. MabVax Therapeutics has a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been immunized against targeted cancers. For more information, visit the company's website at www.mabvax.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive…

Continue Reading

WednesdayDec 07, 2016 5:00 pm

Youngevity International (YGYI) Starts Presentation at LD Micro Main Event

Youngevity International (OTC: YGYI) develops and distributes health and nutrition related products and services primarily through independent direct selling network in the United States and internationally. Through its Direct Sales and Commercial Coffee segments, the company offers approximately 2,500 products, including nutritional products; sports and energy drinks; health and wellness-related services; lifestyle products such as spa, bath, garden and pet-related products; digital products; apparel and fashion accessories; and packaged foods. For more information, visit the company's website at www.ygyi.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions.…

Continue Reading

WednesdayDec 07, 2016 4:30 pm

Inventergy Global (INVT) Starts Presentation at LD Micro Main Event

Inventergy Global (NASDAQ: INVT) operates as an intellectual property (IP) investment and licensing company. It offers corporate licensing model for IP value creation that provides short-term returns and long-term licensing revenue. Inventergy acquires portfolios in the telecommunications industry primarily in core network infrastructure and mobile broadband communications segments. For more information, visit the company's website at www.inventergy.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best…

Continue Reading

WednesdayDec 07, 2016 4:30 pm

Full House Resorts (FLL) Starts Presentation at LD Micro Main Event

Full House Resorts (NASDAQ: FLL) owns, operates, develops, manages or invests in casinos and related hospitality and entertainment facilities. The company owns and operates the Silver Slipper Casino & Hotel in Hancock County, Mississippi, and the Rising Star Casino Resort located in Rising Sun, Indiana. In addition, the company owns and operates Stockman's Casino in Fallon, Nevada, the Grand Lodge Casino at the Hyatt Regency Lake Tahoe Resort, Spa & Casino in Incline Village, Nevada, on the north shore of Lake Tahoe. For more information, visit the company's website atwww.fullhouseresorts.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced…

Continue Reading

WednesdayDec 07, 2016 4:30 pm

Arch Therapeutics (ARTH) Starts Presentation at LD Micro Main Event

Arch Therapeutics (OTC: ARTH) is a biotechnology company developing an innovative, elegant and superior approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care. The underlying technology, exclusively licensed from a leading university, supports an innovative platform of smart materials that fulfill the criteria as a solution for a specialized field we call, "stasis and barrier applications." For more information, visit the company's website at www.archtherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial…

Continue Reading

WednesdayDec 07, 2016 4:30 pm

Kindred Biosciences (KIN) Starts Presentation at LD Micro Main Event

Kindred Biosciences (NASDAQ: KIN) is a development-stage biopharmaceutical company that focuses on the development of therapies for pets. The company's strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. Kindred Biosciences has a deep pipeline of novel drugs and biologics in development across many therapeutic classes. For more information, visit the company's website at www.kindredbio.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000